The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopause

https://doi.org/10.1016/S0165-0378(00)00087-5Get rights and content

Abstract

A large clinical literature suggests that estradiol (E2) plays a critical role in immune function. To further explore the relationship between E2 and immune function, we examined a variety of immunological parameters in a rhesus monkey model of menopause and hormone replacement therapy. Rhesus monkeys (Age, 13.7±2.6 years) were ovariectomized and received either sham (n=10) or estradiol (n=10) replacement implants. Nine months post-ovariectomy, a variety of immunologic parameters were measured. E2-deprivation reduced natural killer cell activity and increased serum soluble gp130 levels. There was a trend for an increased proportion of CD8+ (P=0.12) and HLA-DR+CD3+ cells (P=0.15) and decreased proportion of eosinophils (P=0.11) in the E2-deprived monkeys. There was no difference in leukocyte distribution, CD28, CD56, CD4, CD8/CD45, colony forming units-granulocyte/monocytes formation, peripheral blood mononuclear cell apoptotic rate, or serum TNF, TNF-R1, TNF-R2, IL-6, soluble IL-6R, and IL-1 between the groups. These data demonstrate that E2-deprivation affects several aspects of immune function. These findings may have implications for menopause-associated changes of immune function that occur in women.

Introduction

A large clinical literature suggests that estradiol (E2) plays a critical role in immune function (Cutolo et al., 1995). Specifically, women are more susceptible to autoimmune diseases than men (Ansar Ahmed and Talal, 1989, Jansson and Holmdahl, 1998) and hormone replacement therapy of menopause modulates immune parameters (Brunelli et al., 1996). A variety of mechanisms for this phenomenon have been postulated including E2's ability to regulate cytokine production (Deshpande et al., 1997, Hunt et al., 1997) and inhibit apoptosis of peripheral blood mononuclear cells (Evans et al., 1997, Hofmann-Lehmann et al., 1998). However, these studies are often inconsistent due to differences in subject selection (e.g. differences in menopausal status or time since onset of menopause) and environmental factors (e.g. nutrition or alcohol intake, etc.).

Female rhesus monkeys (Macaca mulatta) have reproductive parameters similar to women. For example, they have 28-day menstrual cycles (Bosu et al., 1973) and undergo menopause in the latter third of life (Roberts et al., 1997, Kaack et al., 1998). In addition to the similarities of normal reproductive endocrinology, monkeys respond similarly as women to several hormone-based interventions, such as surgically induced menopause and E2 replacement therapy (Jayo et al., 1990, Keller et al., 2000). Therefore, rhesus monkeys may serve as an appropriate animal model to explore the effect of menopause on the immune system. This is an important area of exploration because of the impact that hormones have on autoimmune disease and the increasing interest in hormone replacement therapy. Accordingly, the goal of the current study was to explore the effect of long-term E2 deprivation on various immune parameters in rhesus monkeys.

Section snippets

Animals

The study involved twenty pre-menopausal female rhesus monkeys (M. mulatta) aged 10.6–21.1 years (mean ±S.D.=13.7±2.6 years). Their diet consisted of monkey chow (Teklad # 8775, Madison, WI) containing ≈1.0% calcium, ≈0.75% phosphorus, 8.9 IU/g vitamin D, and water ad libitum. Due to its soybean content, the diet contains the following levels of isoflavone phytoestrogens: daidzein (100 ppm) and genistein (120 ppm) per the manufacturer. All animals were housed indoors with constant 12-h

Estradiol levels

To confirm the efficacy of OVX and E2 replacement, serum E2 levels were measured prior to OVX, 2 weeks post-OVX and at 9 months post-OVX. E2 levels were undetectable in the OVX animals (Fig. 1). In contrast, at 2 weeks and 9 months post-OVX, E2 levels were within the range of healthy cycling rhesus monkey peak and trough E2 levels of 25 and 200 pg/ml, respectively (Bosu et al., 1973) for the OVX+E monkeys (Fig. 1). Additionally, FSH levels were elevated in the OVX group, but not the OVX+E group

Discussion

In the current study, long-term E2-deprivation was associated with increased serum soluble gp130 levels and decreased NK activity. These data demonstrate that E2 modulates several immune parameters in the rhesus monkey.

A large body of literature suggests that E2 can modulate immune function. The estrogen receptor (ER) has been found in a variety of murine and human immune cells including thymocytes (Kohen et al., 1998), splenic CD8+ cells (Stimson, 1988, Ishimaru et al., 1999), monocytes,

Acknowledgements

We would like to thank Ms Barbara Stebler for technical support. This work was supported by the National Institutes of Health Grant R01-AG11 970.

References (40)

  • W. Sun et al.

    Estrogen inhibits phorbol ester-induce IκBα transcription and protein degradation

    Biochem. Biophys. Res. Comm.

    (1998)
  • Y. Zhang et al.

    Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations

    J. Nutr.

    (1999)
  • S. Ansar Ahmed et al.

    Sex hormones and autoimmune rheumatic disorders

    Scand. J. Rheumatol.

    (1989)
  • P.V. Bodine et al.

    Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line

    J. Cell. Biochem.

    (1997)
  • P.V. Bodine et al.

    Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts

    Endocrinology

    (1999)
  • W.T. Bosu et al.

    Peripheral plasma levels of oestrone, oestradiol-17beta and progesterone during ovulatory menstrual cycles in the rhesus monkey with special reference to the onset of menstruation

    Acta Endocrinol. (Copenhagen)

    (1973)
  • R. Brunelli et al.

    Hormone replacement therapy affects various immune cell subsets and natural cytotoxicity

    Gynecol. Obstet. Invest.

    (1996)
  • L.R. Chaudhary et al.

    Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: lack of regulation by 17β-estradiol

    Endocrinology

    (1992)
  • D. Cheleuitte et al.

    In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status

    J. Clin. Endocrinol. Metab.

    (1998)
  • M. Cutolo et al.

    Estrogens, the immune response and autoimmunity

    Clin. Exp. Rheumatol.

    (1995)
  • Cited by (0)

    View full text